|
1
|
Quinn BA, Dash R, Azab B, Sarkar S, Das
SK, Kumar S, Oyesanya RA, Dasgupta S, Dent P, Grant S, et al:
Targeting Mcl-1 for the therapy of cancer. Expert Opin Investig
Drugs. 20:1397–1411. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Su J, Zhou L, Xia MH, Xu Y, Xiang XY and
Sun LK: Bcl-2 family proteins are involved in the signal crosstalk
between endoplasmic reticulum stress and mitochondrial dysfunction
in tumor chemotherapy resistance. BioMed Res Int. 2014:2343702014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hartman MŁ and Czyż M: BH3 mimetics as a
strategy to complement anticancer therapies. Postepy Hig Med Dosw
(Online). 66:67–77. 2012.(In Polish).
|
|
4
|
Giménez-Cassina A and Danial NN:
Regulation of mitochondrial nutrient and energy metabolism by BCL-2
family proteins. Trends Endocrinol Metab. 26:165–175. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen ZX and Pervaiz S: Involvement of
cytochrome c oxidase subunits Va and Vb in the regulation of cancer
cell metabolism by Bcl-2. Cell Death Differ. 17:408–420. 2010.
View Article : Google Scholar
|
|
6
|
Lagadinou ED, Sach A, Callahan K, Rossi
RM, Neering SJ, Minhajuddin M, Ashton JM, Pei S, Grose V, O'Dwyer
KM, et al: BCL-2 inhibition targets oxidative phosphorylation and
selectively eradicates quiescent human leukemia stem cells. Cell
Stem Cell. 12:329–341. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mérad-Saïdoune M, Boitier E, Nicole A,
Marsac C, Martinou JC, Sola B, Sinet PM and Ceballos-Picot I:
Overproduction of Cu/Zn-superoxide dismutase or Bcl-2 prevents the
brain mitochondrial respiratory dysfunction induced by glutathione
depletion. Exp Neurol. 158:428–436. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kueck A, Opipari AW Jr, Griffith KA, Tan
L, Choi M, Huang J, Wahl H and Liu JR: Resveratrol inhibits glucose
metabolism in human ovarian cancer cells. Gynecol Oncol.
107:450–457. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Muñoz-Pinedo C, El Mjiyad N and Ricci JE:
Cancer metabolism: Current perspectives and future directions. Cell
Death Dis. 3:e2482012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Deberardinis RJ, Sayed N, Ditsworth D and
Thompson CB: Brick by brick: Metabolism and tumor cell growth. Curr
Opin Genet Dev. 18:54–61. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Andersen JL and Kornbluth S: The tangled
circuitry of metabolism and apoptosis. Mol Cell. 49:399–410. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Green DR, Galluzzi L and Kroemer G: Cell
biology. Metabolic control of cell death. Science. 345:1250256.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suh DH, Kim MK, No JH, Chung HH and Song
YS: Metabolic approaches to overcoming chemoresistance in ovarian
cancer. Ann NY Acad Sci. 1229:53–60. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim HS, Patel K, Muldoon-Jacobs K, Bisht
KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage
J, Owens KM, et al: SIRT3 is a mitochondria-localized tumor
suppressor required for maintenance of mitochondrial integrity and
metabolism during stress. Cancer Cell. 17:41–52. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Finley LWS and Haigis MC: Metabolic
regulation by SIRT3: Implications for tumorigenesis. Trends Mol
Med. 18:516–523. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bell EL, Emerling BM, Ricoult SJH and
Guarente L: SirT3 suppresses hypoxia inducible factor 1α and tumor
growth by inhibiting mitochondrial ROS production. Oncogene.
30:2986–2996. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Allison SJ and Milner J: SIRT3 is
pro-apoptotic and participates in distinct basal apoptotic
pathways. Cell Cycle. 6:2669–2677. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhong JT, Xu Y, Yi HW, Su J, Yu HM, Xiang
XY, Li XN, Zhang ZC and Sun LK: The BH3 mimetic S1 induces
autophagy through ER stress and disruption of Bcl-2/Beclin 1
interaction in human glioma U251 cells. Cancer Lett. 323:180–187.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Song T, Chang X, Zhang Z, Liu Y and Shen
X: S1, a novel pan-BH3 mimetic, induces apoptosis in
Mcl-1-overexpressing cells through Bak. J Pharmacol Sci.
119:330–340. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bol V, Bol A, Bouzin C, Labar D, Lee JA,
Janssens G, Porporato PE, Sonveaux P, Feron O and Grégoire V:
Reprogramming of tumor metabolism by targeting mitochondria
improves tumor response to irradiation. Acta Oncol. 54:266–274.
2015. View Article : Google Scholar
|
|
21
|
Giralt A and Villarroya F: SIRT3, a
pivotal actor in mitochondrial functions: Metabolism, cell death
and aging. Biochem J. 444:1–10. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Scher MB, Vaquero A and Reinberg D: SirT3
is a nuclear NAD+-dependent histone deacetylase that
translocates to the mitochondria upon cellular stress. Genes Dev.
21:920–928. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wei L, Zhou Y, Dai Q, Qiao C, Zhao L, Hui
H, Lu N and Guo QL: Oroxylin A induces dissociation of hexokinase
II from the mitochondria and inhibits glycolysis by SIRT3-mediated
deacetylation of cyclophilin D in breast carcinoma. Cell Death Dis.
4:e6012013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Anderson AS, Roberts PC, Frisard MI,
McMillan RP, Brown TJ, Lawless MH, Hulver MW and Schmelz EM:
Metabolic changes during ovarian cancer progression as targets for
sphingosine treatment. Exp Cell Res. 319:1431–1442. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu N, Xu Y, Sun JT, Su J, Xiang XY, Yi
HW, Zhang ZC and Sun LK: The BH3 mimetic S1 induces endoplasmic
reticulum stress-associated apoptosis in cisplatin-resistant human
ovarian cancer cells although it activates autophagy. Oncol Rep.
30:2677–2684. 2013.PubMed/NCBI
|
|
26
|
Yi CH, Pan H, Seebacher J, Jang IH,
Hyberts SG, Heffron GJ, Vander Heiden MG, Yang R, Li F, Locasale
JW, et al: Metabolic regulation of protein N-alpha-acetylation by
Bcl-xL promotes cell survival. Cell. 146:607–620. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wensveen FM, Alves NL, Derks IAM,
Reedquist KA and Eldering E: Apoptosis induced by overall metabolic
stress converges on the Bcl-2 family proteins Noxa and Mcl-1.
Apoptosis. 16:708–721. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nishikawa T, Bellance N, Damm A, Bing H,
Zhu Z, Handa K, Yovchev MI, Sehgal V, Moss TJ, Oertel M, et al: A
switch in the source of ATP production and a loss in capacity to
perform glycolysis are hallmarks of hepatocyte failure in advance
liver disease. J Hepatol. 60:1203–1211. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou Y, Tozzi F, Chen J, Fan F, Xia L,
Wang J, Gao G, Zhang A, Xia X, Brasher H, et al: Intracellular ATP
levels are a pivotal determinant of chemoresistance in colon cancer
cells. Cancer Res. 72:304–314. 2012. View Article : Google Scholar
|
|
30
|
Khwairakpam AD, Shyamananda MS, Sailo BL,
Rathnakaram SR, Padmavathi G, Kotoky J and Kunnumakkara AB: ATP
citrate lyase (ACLY): A promising target for cancer prevention and
treatment. Curr Drug Targets. 16:156–163. 2015. View Article : Google Scholar
|
|
31
|
Ganapathy-Kanniappan S and Geschwind J-FH:
Tumor glycolysis as a target for cancer therapy: Progress and
prospects. Mol Cancer. 12:152. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sundaresan NR, Samant SA, Pillai VB,
Rajamohan SB and Gupta MP: SIRT3 is a stress-responsive deacetylase
in cardio-myocytes that protects cells from stress-mediated cell
death by deacetylation of Ku70. Mol Cell Biol. 28:6384–6401. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang X, Xiang X, Xia M, Su J, Wu Y, Shen
L, Xu Y and Sun L: Inhibition of JNK3 promotes apoptosis induced by
BH3 mimetic S1 in chemoresistant human ovarian cancer cells. Anat
Rec (Hoboken). 298:386–395. 2015. View Article : Google Scholar
|
|
34
|
Alhazzazi TY, Kamarajan P, Verdin E and
Kapila YL: SIRT3 and cancer: Tumor promoter or suppressor? Biochim
Biophys Acta. 1816:80–88. 2011.PubMed/NCBI
|
|
35
|
Kamarajan P, Alhazzazi TY, Danciu T,
D'silva NJ, Verdin E and Kapila YL: Receptor-interacting protein
(RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and
tumorigenesis. Cancer. 118:5800–5810. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dai SH, Chen T, Wang YH, Zhu J, Luo P, Rao
W, Yang YF, Fei Z and Jiang XF: Sirt3 attenuates hydrogen
peroxide-induced oxidative stress through the preservation of
mitochondrial function in HT22 cells. Int J Mol Med. 34:1159–1168.
2014.PubMed/NCBI
|
|
37
|
Shulga N, Wilson-Smith R and Pastorino JG:
Sirtuin-3 deacetylation of cyclophilin D induces dissociation of
hexokinase II from the mitochondria. J Cell Sci. 123:894–902. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hamanaka RB and Chandel NS: Targeting
glucose metabolism for cancer therapy. J Exp Med. 209:211–215.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang L, Su J, Xie Q, Zeng L, Wang Y, Yi
D, Yu Y, Liu S, Li S and Xu Y: 2-Deoxy-d-glucose sensitizes human
ovarian cancer cells to cisplatin by increasing ER stress and
decreasing ATP stores in acidic vesicles. J Biochem Mol Toxicol.
29:572–578. 2015. View Article : Google Scholar : PubMed/NCBI
|
